
DUBLIN, Nov. 19, 2020 /PRNewswire/ -- The "Hematology Testing Market - Global Outlook and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering.
The hematology testing market share is expected to grow at a CAGR of approx. 5% during the period 2019-2025.
The global hematology testing market is expected to grow at a steady pace during the forecast period. The growth can be attributed to the high prevalence/incidence of several acute, chronic, and infectious diseases, especially blood-related ailments. The prevalence of malaria has increased at a significant rate over the past few years across the globe. According to the WHO, malaria continues to be one of the top five reasons for deaths in the Middle East and Africa. Hence, the increase in routine blood testing to detect infection is positively influencing the market growth.
The market has been witnessing considerable technological advancements in terms of accuracy, efficiency, and test results. The availability of automated hematology analyzers has further led to reduced administrative errors, making the process more effective and efficient in disease diagnosis than manual testing. With the emergence of high throughput analyzers and point-of-care diagnostic devices, several companies are investing in R&D activities with an effort to develop cost-effective and advanced analyzers.
Market Segmentation
The global hematology testing market research report includes a detailed segmentation by product, tests, end-users, and geography. The usage of a wide array of several reagents and test kits to perform hematology tests is increasing revenue opportunities for the consumables segment. The segment generates continuous revenue for vendors as their usage is recurring. Hence, several renowned key players are manufacturing consumables required for both in-house hematology analyzers and other healthcare settings. One of the reasons for the steady growth of consumables is an increase in the sale of high-end instruments by large hospitals, commercial labs, and other facilities handling high volumes of tests.
Routine hematology testing has emerged as a rapidly growing segment in the healthcare industry. The increasing prevalence of diseases and the growing awareness of regular healthcare examinations across the globe are the primary reasons for the growth of routine checkups and overall clinical laboratory testing. An increasing number of urgent care and free-standing emergency room centers is driving companies to invest in hematology testing systems.
The hospitals end-user segment dominated the market in 2019 due to the high volume of hematological tests performed in these settings. The increase in the number of private hospitals, which have their own central laboratories performing a high volume of tests, is driving the segment growth. The availability of skilled healthcare professionals to treat and diagnose several hematological disorders attracts a high number of people to hospitals than other healthcare providers, thereby increasing the revenue of the segment.
Insights by Vendors
The global market is highly dynamic due to the presence of several global and local players, offering a diverse range of products and reagents. Abbott, Sysmex Corporation, Danaher, Boule Diagnostics, Horiba, Mindray, Siemens, and Diatron are the major players in the market. Global players are focusing on developing innovative products and expanding their product portfolio to remain competitive in the market.
They are investing extensively in R&D and product development activities to expand the product portfolio. Abbott Laboratories, Sysmex, Siemens Healthineers, Danaher Corporation, and Boule Diagnostics are focusing constantly on product development. These market players are offering hematology analyzers with new technology to increase their market presence.
Key Questions
1. What is the market size of the global hematology testing market analysis?
2. What are the key factors impacting the growth of the hematology diagnostics market size?
3. What are the leading drivers/trends/restraints in the hematology testing market?
4. Who are the leading vendors and what are their market shares?
5. Which the leading segment/region generating largest revenue to the hematology diagnostics market?
Key Topics Covered:
1 Research Methodology
2 Research Objectives
3 Research Process
4 Scope & Coverage
4.1 Market Definition
4.2 Base Year
4.3 Scope Of The Study
4.4 Market Segments
5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 Market at a Glance
7 Introduction
7.1 Overview
8 Market Opportunities & Trends
8.1 Technological Advancements In Hematology Diagnostics
8.2 Increase In Demand For Point Of Care Hematology Testing
8.3 Emergence Of 6-Part Hematology Analyzers
9 Market Growth Enablers
9.1 Paradigm Shift Towards Automated Hematology Testing
9.2 Increase In Patient Pool Requiring Hematology Tests
9.3 Increasing Blood Transfusions & Donation
9.4 Integration Of Flow-Cytometers With Hematology Analyzers
10 Market Restraints
10.1 Stringent Regulations Coupled With Product Recalls & Safety Concerns
10.2 High Cost Of Initial Investment & Maintenance Requirement Of Hematology Analyzers
10.3 Lower Than Expected Penetration Of Advanced Hematology Analyzers In LMICS
11 Market Landscape
11.1 Market Overview
11.2 Market Size & Forecast
11.3 Five Forces Analysis
12 Product
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
13 Hematology Consumables
13.1 Market Overview
13.2 Market Size & Forecast
13.3 Hematology Consumables: Segmentation By Geography
14 Hematology Instruments/Analyzers
14.1 Market Overview
14.2 Market Size & Forecast
14.3 Hematology Instruments/Analyzers: Segmentation By Geography
14.4 Hematology Analyzers: Segmentation By Part Differentials
14.5 Hematology Analyzers Market By Volume
15 Tests
15.1 Market Snapshot & Growth Engine
15.2 Market Overview
15.3 Routine Hematology Tests
15.4 Special Hematology Tests
16 End-User
16.1 Market Snapshot & Growth Engine
16.2 Market Overview
16.3 Hospitals
16.4 Standard Reference Laboratories
16.5 Blood Banks
16.6 Other End-Users
17 Geography
17.1 Market Snapshot & Growth Engine
17.2 Geographic Overview
Competitive Landscape
Prominent Vendors
- Abbott
- Danaher
- Boule Diagnostics
- HORIBA
- Sysmex
- Shenzhen Mindray Bio-Medical Electronics
- Siemens Healthineers
- NIHON KOHDEN
- Diatron
- Bio-Rad Laboratories
Other Prominent Vendors
- AGAPPE DIAGNOSTICS
- B&E BIO-TECHNOLOGY
- Balio Diagnostics
- CLINDIAG SYSTEMS
- Convergent Technologies
- CPC Diagnostics
- CPM Scientifica
- DIAGON
- Erba Diagnostics
- EDAN Instruments
- Genrui Biotech
- F.Hoffmann-La Roche
- High Technology
For more information about this report visit https://www.researchandmarkets.com/r/pamp8i
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets

Share this article